These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
4. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O; Biggio G Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234 [TBL] [Abstract][Full Text] [Related]
5. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Subramaniam S; Lucki I; McGonigle P Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781 [TBL] [Abstract][Full Text] [Related]
6. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Delfs JM; Kelley AE Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467 [TBL] [Abstract][Full Text] [Related]
7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
8. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393. Williams JE; Woolverton WL Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936 [TBL] [Abstract][Full Text] [Related]
9. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum. Zhang X; Segawa T Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum. Onali P; Olianas MC Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423 [TBL] [Abstract][Full Text] [Related]
11. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats. Saigusa T; Koshikawa N; Kitamura M; Kobayashi M Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458 [TBL] [Abstract][Full Text] [Related]
12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
13. Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation. Kelly E; Willcocks AL; Nahorski SR Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):618-23. PubMed ID: 2819742 [TBL] [Abstract][Full Text] [Related]
14. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L Synapse; 1990; 5(2):113-9. PubMed ID: 2137942 [TBL] [Abstract][Full Text] [Related]
15. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
16. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems. Singh NA; Bush LG; Gibb JW; Hanson GR Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780 [TBL] [Abstract][Full Text] [Related]
17. Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions. Strömberg I; Bickford-Wimer P Brain Res; 1991 Nov; 564(2):279-85. PubMed ID: 1687374 [TBL] [Abstract][Full Text] [Related]
18. Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein. Courtney ND; Howlett AC; Westfall TC Neurosci Lett; 1991 Jan; 122(2):261-4. PubMed ID: 1827517 [TBL] [Abstract][Full Text] [Related]
19. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation. Collins P; Broekkamp CL; Jenner P; Marsden CD Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]